Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mitomycin C analogues with increased metal complexing ability.

B S Iyengar, S M Sami, T Takahashi

    Journal of Medicinal Chemistry
    |September 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Cytokine mRNA expression in an in vitro human skin model, SKIN(2).

    Toxicology in vitro : an international journal published in association with BIBRA·2010
    Same author

    Preclinical antitumor activity of the azonafide series of anthracene-based DNA intercalators.

    Anti-cancer drugs·2001
    Same author

    Analogues of amonafide and azonafide with novel ring systems.

    Journal of medicinal chemistry·2000
    Same author

    Intracellular localization of 6- and 7-substituted 2-[2'-(dimethylamino)ethyl]-1,2-dihydro-3H-dibenz[de,h]isoquino line-1,3-diones (azonafides) is not the limiting factor for their cytotoxicity: an in vitro confocal microscopy study.

    Anti-cancer drugs·1999
    Same author

    Novel antitumor 2-cyanoaziridine-1-carboxamides.

    Journal of medicinal chemistry·1999
    Same author

    In vitro and in vivo testing techniques for allergic contact dermatitis.

    American journal of contact dermatitis : official journal of the American Contact Dermatitis Society·1998
    Same journal

    Development of Indole-3-yl-methylene-thiobarbital Derivatives as Inhibitors of HDAC8 Enzyme Activity.

    Journal of medicinal chemistry·2026
    Same journal

    Discovery of a Potent NAMPT-Targeting PROTAC for the Suppression of Triple-Negative Breast Cancer via Macrophage Reprogramming.

    Journal of medicinal chemistry·2026
    Same journal

    3',4'-Isopropylidene-α-galactosylceramide Enables Multidose Th1 Adjuvanticity Despite Limited Serial Serum IFN-γ Responsiveness.

    Journal of medicinal chemistry·2026
    Same journal

    A Bioorthogonally Cleavable <i>N</i>-Oxide Linker for Prodrug Design: Elucidating the Structure-Cyclization Kinetics Relationships for Controlled Drug Release.

    Journal of medicinal chemistry·2026
    Same journal

    A Melatonin-Catechol Hybrid Molecule Prolongs Lifespan via Regulating ROS and Reprogramming Mitochondrial Metabolism.

    Journal of medicinal chemistry·2026
    Same journal

    Discovery of SD-2301 as a Highly Potent and Selective PROTAC STAT3 Degrader Capable of Achieving Complete Tumor Regression with Single Administration.

    Journal of medicinal chemistry·2026
    See all related articles

    Researchers synthesized novel mitomycin C analogues to enhance metal complexing ability for cancer treatment. One analogue showed superior P388 leukemia activity in mice, though the link between metal complexation and efficacy was unclear.

    Area of Science:

    • Medicinal Chemistry
    • Pharmacology
    • Organic Synthesis

    Background:

    • Mitomycin C is a potent anticancer agent.
    • Enhancing metal complexing ability may improve efficacy.
    • Structure-activity relationships of mitomycin C analogues require further investigation.

    Purpose of the Study:

    • To synthesize new mitomycin C analogues with enhanced metal complexing properties.
    • To evaluate the antitumor activity of these analogues against P388 leukemia in mice.
    • To explore the correlation between Cu(II) complexing ability and antitumor efficacy.

    Main Methods:

    • Synthesis of 23 new mitomycin C analogues.
    • Assessment of Cu(II) complexing ability using UV-Vis spectroscopy.
    • Antitumor activity testing in a P388 leukemia mouse model.

    Related Experiment Videos

    Main Results:

    • One analogue demonstrated significantly higher activity than mitomycin C.
    • Two other analogues exhibited good antitumor activity.
    • Correlation between Cu(II) complexation and activity was ambiguous; optimal compounds were not strong complexers or had specific substituents.

    Conclusions:

    • Novel mitomycin C analogues were synthesized and evaluated.
    • Enhanced metal complexing ability does not directly correlate with improved antitumor activity in this series.
    • Further research is needed to elucidate the precise role of metal complexation in mitomycin C analogue efficacy.